Stephens & Co. Reiterates Overweight on Stoneridge, Maintains $27 Price Target

Stephens & Co. analyst Justin Long reiterates Stoneridge (NYSE:SRI) with a Overweight and maintains $27 price target.

Stephens & Co. analyst Justin Long reiterates Stoneridge (NYSE:SRI) with a Overweight and maintains $27 price target.

Total
0
Shares
Related Posts